Literature DB >> 9027397

Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation.

H Q Lin1, D M Jackson, D M Atrens, M J Christie, I S McGregor.   

Abstract

In a fixed interval 5-s rate-frequency function paradigm with rats, 3,4-methylenedioxymethamphetamine (MDMA; 0.5, 2 and 4 mg/kg) dose-dependently decreased response rate for nucleus accumbens self-stimulation while both D-amphetamine (0.3 and 1 mg/kg) and cocaine (5 and 15 mg /kg) increased response rates. The highest doses of MDMA caused a cessation of responding in many of the rats tested, but in those rats that continued to respond a significant reduction in frequency threshold for self-stimulation was seen. Cocaine and amphetamine dose-dependently reduced frequency threshold in all rats tested. The non-specific serotonin antagonist, methysergide (5 mg/kg), reversed the inhibitory effects of MDMA on response rates and caused all rats to respond following MDMA (4 mg/kg). Methysergide did not affect MDMA's threshold-lowering properties and when administered alone methysergide had not effect on self-stimulation. These results suggest serotonergic involvement in the performance but not reinforcement-modulating effect of MDMA in the self-stimulation paradigm.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9027397     DOI: 10.1016/S0006-8993(96)01210-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content.

Authors:  Margaret C Wardle; Matthew G Kirkpatrick; Harriet de Wit
Journal:  Soc Cogn Affect Neurosci       Date:  2014-03-27       Impact factor: 3.436

2.  Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in rats.

Authors:  Clayton T Bauer; Matthew L Banks; Bruce E Blough; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2015-06-05       Impact factor: 4.530

Review 3.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

4.  Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.

Authors:  C T Bauer; M L Banks; B E Blough; S S Negus
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  Age differences in (±) 3,4-methylenedioxymethamphetamine (MDMA)-induced conditioned taste aversions and monoaminergic levels.

Authors:  Jennifer L Cobuzzi; Kayla A Siletti; Zachary E Hurwitz; Bradley Wetzell; Michael H Baumann; Anthony L Riley
Journal:  Dev Psychobiol       Date:  2013-06-15       Impact factor: 3.038

6.  Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.

Authors:  Maria Elena Reveron; Esther Y Maier; Christine L Duvauchelle
Journal:  Behav Brain Res       Date:  2009-11-03       Impact factor: 3.332

Review 7.  Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns.

Authors:  R De La Garza; K R Fabrizio; A Gupta
Journal:  Psychopharmacology (Berl)       Date:  2006-02-10       Impact factor: 4.530

8.  The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts"

Authors:  Lucas R Watterson; Lauren Hood; Kaveish Sewalia; Seven E Tomek; Stephanie Yahn; Craig Trevor Johnson; Scott Wegner; Bruce E Blough; Julie A Marusich; M Foster Olive
Journal:  J Addict Res Ther       Date:  2012-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.